bosentan anhydrous has been researched along with Arterial Occlusive Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bakx, R; Dogan, K; Klemm, PL | 1 |
| McCulloch, J; Patel, TR | 1 |
| Breu, V; Graham, DI; McAuley, MA; McCulloch, J | 1 |
3 other study(ies) available for bosentan anhydrous and Arterial Occlusive Diseases
| Article | Year |
|---|---|
[A complication of coronary angiography in a female patient with systemic sclerosis].
Topics: Aged; Antihypertensive Agents; Arterial Occlusive Diseases; Bosentan; Coronary Angiography; Female; Humans; Raynaud Disease; Scleroderma, Systemic; Sulfonamides | 2011 |
Postischemic hypoperfusion in transient global ischemia: a role for endothelins?
Topics: Animals; Arterial Occlusive Diseases; Bosentan; Cerebrovascular Circulation; Coronary Disease; Endothelins; Hypotension; Ischemic Attack, Transient; Male; Rats; Rats, Sprague-Dawley; Sulfonamides | 1995 |
The effects of bosentan on cerebral blood flow and histopathology following middle cerebral artery occlusion in the rat.
Topics: Animals; Antipyrine; Arterial Occlusive Diseases; Autoradiography; Bosentan; Brain Ischemia; Carbon Radioisotopes; Cerebral Arteries; Cerebral Cortex; Cerebrovascular Circulation; Endothelin Receptor Antagonists; Isotope Labeling; Laser-Doppler Flowmetry; Male; Rats; Rats, Sprague-Dawley; Sulfonamides | 1996 |